Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis
Part of paid clinical trials in Belmont, Massachusetts.
- Sponsor
- Mclean Hospital
- Study ID
- NCT06477406
- Phase
- PHASE2
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cannabidiol — DRUGCustom formulation of a hemp-derived sublingual solution that is high in CBD and includes other cannabinoids and terpenes.
- Placebo — DRUGAn active placebo containing supplemental terpenes matched to the high-CBD product.
Study Details
Despite the proliferation of cannabis and cannabinoid products in recent years, little research has been done to determine the impact of these products on womens health conditions, including endometriosis. This study is designed to assess the impact of a custom-formulated, hemp-derived, full-spectrum, high-CBD product vs. placebo on clinical symptoms and biomarkers over the course of 12 weeks of treatment in patients with endometriosis. This project will provide information that does not currently exist on the potential efficacy of a cannabinoid-based sublingual product for endometriosis.
Key Dates
- Start date
- Feb 27, 2024
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: High-CBD Sublingual ProductA custom-formulated, hemp-derived, full-spectrum high-CBD sublingual solution; 0.75mL of solution will be self-administered three times daily (TID) for the duration of the CBD phase.
- Placebo Comparator: PlaceboPlacebo solution (0.75mL) will be self-administered TID for the duration of the placebo phase.
Primary Outcome Measure
Visual Analog Scale (VAS) [ Time Frame: 12 weeks ]
Central Contacts
- Staci Gruber, PhD617-855-2762
- Rosie Smith, M.S.617-855-2908
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| McLean Hospital | Belmont | Massachusetts | 02478 |
Find similar trials in Belmont, MA
By condition
By specialty
By research site
Related Studies
- PET/MRI for Evaluation of EndometriosisEnrolling By Invitation · Massachusetts General Hospital · Charlestown, Massachusetts
- Glycemic Regulation as Endometriosis Adjunct TreatmentPHASE2 · Recruiting · Boston Children's Hospital · Boston, Massachusetts
- Cardiovascular Disease Risk in Women With EndometriosisEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical CancerRecruiting · Mayo Clinic · Scottsdale, Arizona